BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Wu X, Tsilimigras DI, Poultsides G, Rocha F, Abbott DE, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined. J Surg Oncol 2019;120:1302-10. [DOI: 10.1002/jso.25753] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Schmocker RK, Wright MJ, Ding D, Javed AA, Cameron JL, Lafaro K, Burns WR, He J, Wolfgang CL, Burkhart RA. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin. J Surg Oncol 2021;123:416-24. [PMID: 33125737 DOI: 10.1002/jso.26285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Spolverato G, Maithel SK, Pawlik TM. Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy. J Surg Oncol 2020;122:442-9. [PMID: 32470159 DOI: 10.1002/jso.25978] [Reference Citation Analysis]
3 Andreasi V, Partelli S, Muffatti F, Manzoni MF, Capurso G, Falconi M. Update on gastroenteropancreatic neuroendocrine tumors. Dig Liver Dis. 2021;53:171-182. [PMID: 32912771 DOI: 10.1016/j.dld.2020.08.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kowalsky SJ, Nassour I, AlMasri S, Paniccia A, Zureikat AH, Choudry HA, Pingpank JF. Omission of Right Hemicolectomy May be Safe for Some Appendiceal Goblet Cell Adenocarcinomas: A Survival Analysis of the National Cancer Database. Ann Surg Oncol 2021;28:8916-25. [PMID: 34409541 DOI: 10.1245/s10434-021-10191-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sun S, Wang W, He C. Development and Validation of Prognostic Nomograms for Patients with Duodenal Neuroendocrine Neoplasms. Med Sci Monit 2020;26:e922613. [PMID: 32564052 DOI: 10.12659/MSM.922613] [Reference Citation Analysis]
6 Xiao K, Swierczynski S, Xiao G. Small, low-grade ampullary neuroendocrine tumor presenting with metastasis and multiple synchronous tumors in a patient with neurofibromatosis type 1: a case report with literature review. J Surg Case Rep 2021;2021:rjab076. [PMID: 33815755 DOI: 10.1093/jscr/rjab076] [Reference Citation Analysis]
7 Fermi F, Andreasi V, Muffatti F, Crippa S, Tamburrino D, Partelli S, Falconi M. How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery. Curr Oncol Rep. [DOI: 10.1007/s11912-022-01200-8] [Reference Citation Analysis]
8 Vanoli A, Grami O, Klersy C, Milanetto AC, Albarello L, Fassan M, Luchini C, Grillo F, Spaggiari P, Inzani F, Uccella S, Parente P, Nappo G, Mattiolo P, Milione M, Pietrabissa A, Cobianchi L, Schiavo Lena M, Partelli S, Di Sabatino A, Sempoux C, Capella C, Pasquali C, Doglioni C, Sessa F, Scarpa A, Rindi G, Paulli M, Zerbi A, Falconi M, Solcia E, La Rosa S. Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases. Endocr Pathol 2022. [PMID: 35553369 DOI: 10.1007/s12022-022-09720-6] [Reference Citation Analysis]
9 Cho HJ, Jang JY, Jeong SY, Kang IC, Lee SH, Choi SH. Robotic limited local resection of duodenal juxta-ampullary neoplasms. Int J Med Robot 2021;17:e2192. [PMID: 33125798 DOI: 10.1002/rcs.2192] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Tran CG, Sherman SK, Suraju MO, Nayyar A, Gerke H, Abiad RGE, Chandrasekharan C, Ear PH, O'Dorisio TM, Dillon JS, Bellizzi AM, Howe JR. Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection. Ann Surg Oncol 2021. [PMID: 34515889 DOI: 10.1245/s10434-021-10774-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]